Use of Carnosine for Oxidative Stress Reduction in Different Pathologies
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The main properties and biological effects of the antioxidant carnosine, the natural dipeptide β‐alanyl‐L‐histidine, are considered. Data on the effective use of carnosine in different pathologies are presented. Special attention is paid to issues of use of carnosine in neurologic and mental diseases, in alcoholism as well as in physiological states accompanied by activation of free‐radical processes and formation of oxidative stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free Radicals in Biology and Medicine
Halliwell, B., & Gutteridge, J. M. C. (2015) · doi:10.1093/acprof:oso/9780198717478.001.0001 · Cited by 8,990
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630 · cited 2×
“ROS: Reactive oxygen species OS: Oxidative stress AGE products: Advanced glycation end products Nrf2: Nuclear factor (erythroid-derived 2) like 2.”
BackgroundModulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
Acetaldehyde adducts in alcoholic liver disease
Setshedi, M., Wands, J. R., & de la Monte, S. M. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.3.12288 · Cited by 365
The Role of Oxidative Stress in Depressive Disorders
Maria Michel, T., Pulschen, D., & Thome, J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803523554 · Cited by 268 · cited 1×
“It is known that OS develops in Parkinson’s and Alzheimer’s diseases [52], acute ischemic stroke [53], schizophrenia [54], depression [55], addictive disorders, alcoholism [56–58], and so forth.”
BackgroundImportant role of muscle carnosine in rowing performance
Baguet, A., Bourgois, J., Vanhee, L., Achten, E., & Derave, W. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00141.2010 · Cited by 182 · cited 1×
“Carnosine is applied for the acceleration of recovery of tired muscles and increase in their working capacity in athletes [78] and in healthy elderly persons with active lifestyle [79].”
BackgroundCarnisone Increases Efficiency of DOPA Therapy of Parkinson's Disease: A Pilot Study
Boldyrev, A., Fedorova, T., Stepanova, M., Dobrotvorskaya, I., Kozlova, E., Boldanova, N., Bagyeva, G., Ivanova-Smolenskaya, I., & Illarioshkin, S. (2008) · Rejuvenation Research · doi:10.1089/rej.2008.0716 · Cited by 123 · cited 1×
“in treatment of Parkinson’s disease [60].”
Cited by
Ethanol Metabolism in the Liver, the Induction of Oxidant Stress, and the Antioxidant Defense System
Contreras-Zentella, M. L., Villalobos-García, D., & Hernández-Muñoz, R. (2022) · Antioxidants · doi:10.3390/antiox11071258 · Cited by 185
Caruso, G., Caraci, F., & Jolivet, R. B. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.004 · Cited by 110
Immunological Dysfunction in Autism Spectrum Disorder: A Potential Target for Therapy
Marchezan, J., Winkler dos Santos, E. G. A., Deckmann, I., & Riesgo, R. D. S. (2018) · Neuroimmunomodulation · doi:10.1159/000492225 · Cited by 70
Metadata
- Authors
- Prokopieva, V. D., Yarygina, E. G., Bokhan, N. A., & Ivanova, S. A.
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2016-01
- Volume
- 2016
- Issue
- 1
- Pages
- 2939087-2939087
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- OpenAlex
- W2264463083
- Cited by
- 129
- References
- 9
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.